0.0286
0.0000
(0.00%)
At close: January 30 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-29,485.0000
-29,485.0000
-34,510.0000
-38,356.0000
-27,541.0000
Investing Cash Flow
5,946.0000
5,946.0000
-2.0000
-5.0000
181.0000
Financing Cash Flow
26,001.0000
26,001.0000
-103.0000
33,330.0000
52,922.0000
End Cash Position
5,212.0000
5,212.0000
2,724.0000
37,339.0000
42,370.0000
Income Tax Paid Supplemental Data
371.0000
371.0000
244.0000
209.0000
300.0000
Capital Expenditure
--
--
--
-5.0000
-45.0000
Issuance of Capital Stock
20,001.0000
20,001.0000
512.0000
33,229.0000
52,641.0000
Issuance of Debt
6,000.0000
6,000.0000
--
--
--
Repurchase of Capital Stock
--
--
-615.0000
--
--
Free Cash Flow
-29,485.0000
-29,485.0000
-34,510.0000
-38,361.0000
-27,586.0000
12/31/2020 - 5/8/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OSTX OS Therapies Incorporated
1.8400
-5.64%
GLTO Galecto, Inc.
4.9600
-1.20%
AMBS Amarantus BioScience Holdings, Inc.
0.0001
0.00%
TRVN Trevena, Inc.
1.6700
+5.70%
PASG Passage Bio, Inc.
0.5840
-0.14%
MBRX Moleculin Biotech, Inc.
1.5100
-1.95%
PBLA Panbela Therapeutics, Inc.
0.3600
+10.70%
ENLV Enlivex Therapeutics Ltd.
1.1000
-0.90%
VCNX Vaccinex, Inc.
1.2500
-3.10%
ABEO Abeona Therapeutics Inc.
5.54
+1.28%